Abstract:Background: When a genetic mutation is identified in a family member (proband), internationally, it is usually the proband's or another responsible family member's role to disclose the information to at-risk relatives. However, both active and passive non-disclosure in families occurs: choosing not to communicate the information or failing to communicate the information despite intention to do so, respectively. The ethical obligations to prevent harm to at-risk relatives and promote the duty of care by genetic health professionals (GHPs) is in conflict with Privacy laws and professional regulations that prohibits disclosure of information to a third party without the consent of the proband (duty of confidentiality). In New South Wales (NSW), Australia, amendments to Privacy legislation permits such disclosure to living genetic relatives with the process defined under guidelines although there is no legal duty to warn. This study assessed NSW GHP's awareness and experience of the legislation and guidelines. Methods: An online survey collected demographics; theoretical knowledge; clinical scenarios to assess application knowledge; attitudes; confidence; experience with active non-disclosure. A link to correct answers was provided after completion. Knowledge scores above the median for non-parametric data or above the mean for parametric data were classified as 'good' or 'poor'. Chi square tests assessed associations between confidence and knowledge scores. Results: While many of the 37 participants reported reading the guidelines, there was limited awareness of their scope and clinical application; that there is no legal duty to warn; and that the threat does not need to be imminent to warrant disclosure. No association between confidence and 'good' theoretical or applied clinical knowledge was identified. Uncertainty of their professional responsibility was identified and in the several case examples of active non-disclosure that were reported this uncertainty reflected the need for further understanding of the guidelines in regard to the processes required before disclosure was initiated. Conclusions: There is a need for further education and training about the guidelines associated with the legislation that would be relevant to support disclosure. The findings may inform future strategies to support introduction of policy changes in other jurisdictions where similar regulatory regimes are introduced.

Exploring genetic counselors' experiences with non‐paternity in clinical settings

Exploring genetic counselors' interest and role in transitional care discussions for pediatric patients with neurodevelopmental conditions

Exploring genetic counselors' practice of discussing clinical trials with patients

Disclosure to genetic relatives without consent - Australian genetic professionals' awareness of the health privacy law

Clinician perspectives on policy approaches to genetic risk disclosure in families

Genetic counseling for fetal sex prediction by NIPT: Challenges and opportunities

Genetic counselors' and community clinicians' implementation and perceived barriers to informed consent during pre‐test counseling for hereditary cancer risk

Evolving perspectives on genetic discrimination in health insurance among health care providers

Navigating the Impact of the 21st Century Cures Act Final Rule: A National Survey of U.S. Genetic Counselors

Familial genetic risks: how can we better navigate patient confidentiality and appropriate risk disclosure to relatives?

Navigating the Impact of the 21st Century Cures Act Final Rule: A National Cross-Sectional Survey of U.S. Genetic Counselors

Managing Couple Conflict During Prenatal Counseling Sessions: An Investigation of Genetic Counselor Experiences and Perceptions

Where is the "Counseling" in Prenatal Genetic Counseling?

Reproductive justice advocacy efforts among genetic counselors and family planning providers

"The truth should not be hidden": Experiences and recommendations of individuals making NPE discoveries through genetic genealogy databases

Professionals' views on providing personalized recurrence risks for de novo mutations: Implications for genetic counseling

Parent‐reported genetic counselor adherence to the NSGC practice resource for communicating a potential prenatal diagnosis: Impact on the Down syndrome diagnosis experience

Parental request for familial carrier testing in early childhood: The genetic counseling perspective

Experiences of genetic counselors practicing in multiple languages: Progress and places for improvement

The role of patient-reported experiences in disclosing genetic prenatal testing: Findings from a large-scale survey on pregnant women

Experiences of individuals receiving "Not Parent Expected" results through direct‐to‐consumer genetic testing